Re-appointment of M/s NP Rajput & Co as Internal Auditor for FY 2026-27, at the Board Meeting held on 26th May, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eiko Lifesciences Ltd's Board of Directors, in a meeting held on 26th May 2026, approved the re-appointment of M/s NP Rajput & Co as Internal Auditor for Financial Year 2026-27. The appointment was recommended by the Audit Committee. The firm has experience in income tax compliance, GST compliance, accounting, internal audit, and GST audit. No relationship exists between the appointed firm and the company's directors. The disclosure is made under SEBI Regulation 30 read with Schedule III of the LODR Regulations and a recent SEBI circular.
This is a routine governance filing with no material impact on the stock price or shareholder value. It reflects standard compliance with audit committee recommendations.